Yıldız, Oğuzhan, et al. “Reduced Efficacy of Nivolumab Following Prior Immunotherapy in Metastatic Renal Cell Carcinoma: Implications for Sequential Immune Checkpoint Inhibition”. EXPERIMENTAL BIOMEDICAL RESEARCH, vol. 9, no. 1, Jan. 2026, pp. 1-9, doi:10.30714/j-ebr.2026.262.